ES2081502T3 - Envolturas viricas artificiales. - Google Patents

Envolturas viricas artificiales.

Info

Publication number
ES2081502T3
ES2081502T3 ES91919952T ES91919952T ES2081502T3 ES 2081502 T3 ES2081502 T3 ES 2081502T3 ES 91919952 T ES91919952 T ES 91919952T ES 91919952 T ES91919952 T ES 91919952T ES 2081502 T3 ES2081502 T3 ES 2081502T3
Authority
ES
Spain
Prior art keywords
artificial viral
wraps
viral envelopes
production
artificial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91919952T
Other languages
English (en)
Inventor
Hans Schreier
Ramesh Chander
Arlene A Stecenko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Florida
Original Assignee
University of Florida
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Florida filed Critical University of Florida
Application granted granted Critical
Publication of ES2081502T3 publication Critical patent/ES2081502T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Prostheses (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCUBRIO LA PRODUCCION DE ENVOLTURAS VIRICAS ARTIFICIALES MEDIANTE UNA NUEVA TECNICA DE DIALISIS POR "DOBLE DETERGENTE". ESTA ESPECIALMENTE ILUSTRADA LA PRODUCCION DE ENVOLTURAS VIRICAS DEL HIV-1 Y RSV. LAS RESULTANTES ENVOLTURAS VIRICAS ARTIFICIALES SON IDENTICAS A LAS DE VIRUS NATURALES, ESENCIALMENTE RESPECTO A LAS CARACTERISTICAS RELEVANTES PARA LA INMUNOGENETICA.
ES91919952T 1990-10-19 1991-10-17 Envolturas viricas artificiales. Expired - Lifetime ES2081502T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60064190A 1990-10-19 1990-10-19

Publications (1)

Publication Number Publication Date
ES2081502T3 true ES2081502T3 (es) 1996-03-16

Family

ID=24404456

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91919952T Expired - Lifetime ES2081502T3 (es) 1990-10-19 1991-10-17 Envolturas viricas artificiales.

Country Status (8)

Country Link
EP (1) EP0555333B1 (es)
JP (1) JP3414395B2 (es)
AT (1) ATE132034T1 (es)
DE (1) DE69115924T2 (es)
DK (1) DK0555333T3 (es)
ES (1) ES2081502T3 (es)
GR (1) GR3018918T3 (es)
WO (1) WO1992006677A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI303663B (en) * 2000-02-02 2008-12-01 Kaneda Yasufumi Inactivated virus envelope
ATE536550T1 (de) 2000-10-06 2011-12-15 Life Technologies Corp Halbleiter nanokristalle enthaltende transfektibare mizellen
US20050059031A1 (en) 2000-10-06 2005-03-17 Quantum Dot Corporation Method for enhancing transport of semiconductor nanocrystals across biological membranes
EP1447080A1 (en) 2003-02-13 2004-08-18 Bestewil Holding B.V. Method for producing virosome-like particles

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2650502C3 (de) * 1976-11-04 1980-01-17 Karl Dr.Med. 7302 Ostfildern Theurer Herstellung von Liposomen welche Arzneistoffe enthalten
EP0032578B1 (de) * 1980-01-16 1984-07-25 Hans Georg Prof. Dr. Weder Verfahren und Dialysiereinrichtung zur Herstellung von Bilayer-Vesikeln und Verwendung der Bilayer-Vesikel
DE3173713D1 (en) * 1980-09-05 1986-03-20 Frappier Armand Inst Formation of an immunosome exclusively made of viral antigens reconstituted on an artificial membrane
LU86736A1 (fr) * 1987-01-15 1988-08-23 Univ Bruxelles Liposomes sensibilises a des molecules antigeniques de parasites intracellulaires,procede pour les preparations et leurs applications comme moyens de diagnostic et comme agents d'immunisation
IL86650A0 (en) * 1987-06-30 1988-11-30 Biophor Corp Animal derived cells and liposomes,having an antigenic protein incorporated into their membrane
AU626797B2 (en) * 1987-09-08 1992-08-13 Albany Medical College Immunogenic composites capable of selectively inducing antibody production, pharmaceutical compositions employing the same and method of selectively inducing antibody production

Also Published As

Publication number Publication date
JPH06502412A (ja) 1994-03-17
DE69115924T2 (de) 1996-05-23
DE69115924D1 (de) 1996-02-08
EP0555333B1 (en) 1995-12-27
WO1992006677A1 (en) 1992-04-30
JP3414395B2 (ja) 2003-06-09
ATE132034T1 (de) 1996-01-15
DK0555333T3 (da) 1996-04-29
GR3018918T3 (en) 1996-05-31
EP0555333A1 (en) 1993-08-18

Similar Documents

Publication Publication Date Title
ATE163197T1 (de) Albumin-derivate mit therapeutischer funktion
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
DK0634927T3 (da) Behandling og profylakse af sygdomme forårsaget af parasitter eller bakterier
NO832749L (no) Pumpbare konsentrerte polymersuspensjoner.
ATE353017T1 (de) Herstellung von impstoffen zür vorbeugung von pathogenen zuständen einer hiv retroviraler infektion
ES2081502T3 (es) Envolturas viricas artificiales.
ATE84217T1 (de) Fragmente und fraktionen von heparin mit wirkung gegen hiv.
CO5050392A1 (es) Pestivirus atenuados
ATE127526T1 (de) Verfahren zur herstellung von natürlichem hiv- glykoprotein 160.
ES2072975T3 (es) Mezcla de esterilizante y metodo de esterilizacion.
BR9610932A (pt) Processo para armazenar microorganismos, composição de microorganismos e utilização da mesma
ES2174548T3 (es) Liposomas que contienen construcciones de peptidos con multiples ramificaciones para uso contra el virus de inmunodeficiencia humana.
CY1106318T1 (el) Χρηση ινωδων για την παρασκευη ενος φαρμακου χρησιμου στην θepαπεια της συμφορητικης καρδιακης ανεπαρκειας
ES2088458T3 (es) Fraccion antiviral de extracto acuoso de lentinus edodes.
FI881123A (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
ES2043527B1 (es) Subconjunto de anillo de admision a baja presion con codales integrales.
ATE62599T1 (de) Verwendung einer loesung von alpha-chymotrypsin.
DK0516660T3 (da) Anvendelse af S-adenosylmethionin som middel mod virale infektioner med retrovira
ES2162123T3 (es) Dihidrato del (2r,3s)-3-terc.-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-10beta-diacetoxi-2alfa-benzoiloxi-5beta,20-epoxi-1-hidroxi-9-oxo-19-nor-ciclopropa(g)tax-11-eno-13alfa-ilo y su procedimiento de preparacion.
ES2124258T3 (es) Produccion del virus de la hepatitis a.
IT1244529B (it) Peptidi sintetici atti a potenziare l'infettivita' del virus hiv-1
ES2058357T3 (es) Eteres biciclicos.
FR2786488B1 (fr) Mutants de la gp120 et leurs applications biologiques
RO98172B1 (ro) Proteza pentru sinus si procedeu de realizare
DE69420425D1 (de) Die Herstellung von 3-Alkylamino-2-Piperazinylpyridinen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 555333

Country of ref document: ES